G89.12 Insurance Policy Changes

ICD-10 G89.12 is officially defined as "Acute post-thoracotomy pain." code G89.12 is referenced in 7 tracked payer policy changes from Independence Blue Cross and Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code G89.12 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Independence Blue Cross · Effective Dec 29, 2025Medium impact
MA05.006l, Transcutaneous Electrical Nerve Stimulators (TENS) and Associated Supplies
Independence Blue Cross reissued MA05.006l on 10/28/2026 to communicate its continuing position on TENS coverage; the policy itself became effective 12/29/2025 with clarified medically necessary criteria for chronic pain (other than low back pain) and revised experimental/investigational criteria. A specific criterion requiring ≥50% pain reduction has been deleted from the medically necessary section, streamlining approval requirements for TENS trial periods.
Independence Blue Cross · Effective Dec 29, 2025Medium impact
05.00.74l, Transcutaneous Electrical Nerve Stimulators (TENS) and Associated Supplies
Independence Blue Cross revised policy 05.00.74l for TENS devices effective 12/29/2025, clarifying medically necessary criteria for chronic pain (other than lower back pain) and experimental/investigational criteria. The policy REMOVED the requirement for demonstrating at least 50% pain reduction with objective evidence (e.g., decreased opioid usage, improved range of motion, VAS scores) as a continuation criterion after the initial trial period. Billing teams must update their prior authorization and claims review processes to align with the relaxed documentation requirements for continued TENS coverage.
Independence Blue Cross · Effective Oct 1, 2025Medium impact
MA05.006k, Transcutaneous Electrical Nerve Stimulators (TENS) and Associated Supplies
Independence Blue Cross updated MA05.006k to MA05.006l, effective 10/01/2025, replacing the broad ICD-10 code R10.2 (pelvic and perineal pain) with four more specific codes (R10.21, R10.22, R10.23, R10.24) for TENS device coverage criteria. This is an ICD-10 code maintenance update that requires billing teams to use laterality-specific and anatomically precise codes when documenting TENS eligibility for pelvic/perineal pain conditions.
Aetna · Identified Aug 18, 2026Medium impact
Nerve Blocks (CPB 0863, reviewed 2026-07-23)
Aetna Clinical Policy Bulletin 0863 covers nerve blocks and lists which ones it considers medically necessary. Covered uses include adductor canal, femoral, fascia iliaca, erector spinae plane and transversus abdominis plane blocks for post-operative pain after specific surgeries, and celiac plexus block for cancer pain, while peripheral nerve blocks for chronic pain are covered only as an active component of a comprehensive pain management program. Blocks listed as experimental and investigational include genicular nerve blocks and peripheral nerve blocks used as the sole treatment for chronic non-malignant pain, because the effectiveness of these approaches has not been established.
Aetna · Identified Aug 18, 2026Medium impact
Iontophoresis (CPB 0229, reviewed 2026-04-23)
Aetna considers iontophoresis medically necessary for delivering local anesthetic before emergent skin puncture or dermatological procedures, for intractable disabling primary focal hyperhidrosis of the axillae, palms or soles when the stated criteria are met, for short-term iontophoretic fentanyl for acute postoperative pain, and for the sweat test by pilocarpine iontophoresis to diagnose cystic fibrosis. The policy lists many other uses as experimental, investigational or unproven, including acetic acid for rotator cuff disease, heel pain and epicondylitis, corticosteroid or NSAID iontophoresis for musculoskeletal disorders, onychomycosis and tinnitus, because of insufficient evidence of its effectiveness. CPT 97033 is covered for iontophoresis only when the selection criteria are met.
Independence Blue Cross · Effective Dec 29, 2025Low impact
05.00.74l, Transcutaneous Electrical Nerve Stimulators (TENS) and Associated Supplies
Independence Blue Cross reissued medical policy 05.00.74l on 10/28/2026 with no substantive changes to TENS device coverage criteria. The policy clarifies medically necessary criteria for chronic pain (other than lower back pain) and experimental/investigational criteria. A prior change effective 12/29/2025 removed a specific pain reduction threshold requirement (50% reduction) from continued coverage criteria. This is a reissue communicating the company's continuing position; verify current applicability for your practice's active plans.
Independence Blue Cross · Effective Oct 1, 2025Low impact
05.00.74k, Transcutaneous Electrical Nerve Stimulators (TENS) and Associated Supplies
Independence Blue Cross updated TENS policy 05.00.74k to 05.00.74l, replacing the single ICD-10 code R10.2 (Pelvic and perineal pain) with four more specific codes (R10.21, R10.22, R10.23, R10.24) effective 10/01/2025. This is a routine ICD-10 CM coding update to align with current coding specificity requirements; coverage criteria and billing codes remain unchanged.

Watch G89.12

Get one email when a payer policy names G89.12, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

FREQUENTLY ASKED QUESTIONS

What insurance policy changes affect code G89.12?

There are 7 tracked policy changes affecting code G89.12, including updates from Independence Blue Cross, Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code G89.12?

Payers that have issued tracked updates for code G89.12 include: Independence Blue Cross, Aetna.

How do I get notified when code G89.12 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code G89.12. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code G89.12?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

All billing codes J3590 C9399 J3490 99215 99213 99202

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

MA05.006l, Transcutaneous Electrical Nerve Stimulators (TENS) and Associated Supplies

05.00.74l, Transcutaneous Electrical Nerve Stimulators (TENS) and Associated Supplies

MA05.006k, Transcutaneous Electrical Nerve Stimulators (TENS) and Associated Supplies

Nerve Blocks (CPB 0863, reviewed 2026-07-23)

Iontophoresis (CPB 0229, reviewed 2026-04-23)

05.00.74l, Transcutaneous Electrical Nerve Stimulators (TENS) and Associated Supplies

05.00.74k, Transcutaneous Electrical Nerve Stimulators (TENS) and Associated Supplies

What insurance policy changes affect code G89.12?

Which payers have updated policy for code G89.12?

How do I get notified when code G89.12 policy changes?

Why do payers change policies for code G89.12?